Julio Casoy

No ORCID on file · 13 papers in corpus · active 2006-2016

Study types

  • article 9
  • review 3
  • other 1

Condition tags

  • endometriosis 8
  • mesh:D004715 5
  • adenomyosis 5
  • dysmenorrhea 2
  • infertility 2
article 2016

International Journal of Women’s Health Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain

article 2013

Effect of a hormone-releasing intrauterine system (Mirena ® ) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection

article 2013
International journal of women's health ·doi:10.2147/ijwh.s55210

Endometriosis is a chronic disease in which a persistent state of heightened inflammation is maintained by nuclear factor-kappa B (NF-κB) activation. The progestins present in oral contraceptives are potent inhibitors of NF-κB translocation…

article 2013
International journal of women's health ·doi:10.2147/ijwh.s45093

BACKGROUND: The presence of aromatase and cyclooxygenase-2 (Cox-2) expression was investigated in the endometrium of patients with idiopathic menorrhagia or adenomyosis. The effect of oral contraceptives administered in extended regimens on…

article 2012
International journal of women's health ·doi:10.2147/ijwh.s36825

BACKGROUND: The effect of resveratrol on the management of endometriosis-related pain was investigated in 12 patients who failed to obtain pain relief during use of an oral contraceptive containing drospirenone + ethinylestradiol. METHODS A…

other 2012
International journal of women's health ·doi:10.2147/IJWH.S29154

OBJECTIVE: To investigate whether aromatase expression in the eutopic endometrium correlates with the presence and severity of endometriosis in patients with infertility and/or dysmenorrhea undergoing laparoscopy and hysteroscopy. PATIENTS…

article 2012
International journal of women's health ·doi:10.2147/ijwh.s30087

OBJECTIVE: To investigate the effect of a levonorgestrel-releasing intrauterine system (Mirena(®)) on aromatase and cyclooxygenase-2 (Cox-2) expression in the endometrium of patients with adenomyosis who were submitted to endometrial resect…

review 2012
Women's health (London, England) ·doi:10.2217/whe.12.52

Epigenetic changes favoring the transcription of the aromatase gene in the endometrium allow endometrial cells to survive in ectopic locations by producing estrogens that spare them from destruction through activated macrophages. Local estr…

review 2009
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590802627647

Aromatase expression in the endometrium seems to play a pivotal role in the development of endometriotic lesions. Because inflammatory mediators such as prostaglandin E2 appear to activate aromatase in the cells of the endometrial stroma, i…

article 2008
Contraception ·doi:10.1016/j.contraception.2008.07.002
review 2008
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625180701712745

The use of combined oral contraceptives (COCs) is associated with a reduced risk of developing endometriosis, myomas, and endometrial and ovarian carcinoma. The mechanisms involved are multiple; next to ovulation suppression, a reduction in…

article 2008
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590801890816

OBJECTIVE: To determine the effect of oral contraceptives containing gestodene on aromatase expression in the endometrium of patients diagnosed with endometriosis. PATIENTS AND METHODS: Endometrial biopsies were taken at the time of laparos…

article 2006
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590601005375

OBJECTIVES: To determine whether aromatase expression in the eutopic endometrium and adenomyotic foci is affected by previous use of oral contraceptives containing gestodene, and to determine whether changes in cyclooxygenase-2 (COX-2) expr…